Showing results (231-240 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|June 27, 2020
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trialNagesh Kalakonda, Marie Maerevoet, Federica Cavallo, et al.
The Lancet. Haematology|June 27, 2020
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trialElias Jabbour, Guillaume Richard-Carpentier, Yuya Sasaki, et al.
The Lancet. Haematology|June 27, 2020
Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility studyObiageli E Nnodu, Alayo Sopekan, Uche Nnebe-Agumadu, et al.
The Lancet. Haematology|July 4, 2020
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional studyGeorge Goshua, Alexander B Pine, Matthew L Meizlish, et al.
The Lancet. Haematology|November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialChristoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
The Lancet. Haematology|December 11, 2019
Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statementKris M Mahadeo, Rajinder Bajwa, Hisham Abdel-Azim, et al.
The Lancet. Haematology|December 16, 2019
Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trialAndrew M Brunner, Traci M Blonquist, Daniel J DeAngelo, et al.
The Lancet. Haematology|February 29, 2020
Comparison of international societal guidelines for the diagnosis of suspected pulmonary embolism during pregnancyStuart L Cohen, Chinara Feizullayeva, John A McCandlish, et al.
The Lancet. Haematology|March 15, 2020
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trialMarc S Raab, Monika Engelhardt, Antje Blank, et al.
The Lancet. Haematology|January 16, 2019
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a studyAnas Younes, Joshua Brody, Cecilia Carpio, et al.
Pageof 73